Compare PDSB & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDSB | TCBS |
|---|---|---|
| Founded | 2005 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 46.3M |
| IPO Year | N/A | N/A |
| Metric | PDSB | TCBS |
|---|---|---|
| Price | $0.87 | $15.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 965.2K | 3.3K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $15,268,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.43 |
| Revenue Growth | N/A | ★ 54.88 |
| 52 Week Low | $0.70 | $14.85 |
| 52 Week High | $2.28 | $19.40 |
| Indicator | PDSB | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 50.75 |
| Support Level | $0.70 | $15.90 |
| Resistance Level | $0.94 | $16.01 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 71.67 | 92.31 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.